Literature DB >> 19586940

Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.

Qian An1, Sarah L Wright, Anthony V Moorman, Helen Parker, Mike Griffiths, Fiona M Ross, Teresa Davies, Christine J Harrison, Jon C Strefford.   

Abstract

The dic(9;20)(p11-13;q11) is a recurrent chromosomal abnormality in patients with acute lymphoblastic leukemia. Although it results in loss of material from 9p and 20q, the molecular targets on both chromosomes have not been fully elucidated. From an initial cohort of 58 with acute lymphoblastic leukemia patients with this translocation, breakpoint mapping with fluorescence in situ hybridization on 26 of them revealed breakpoint heterogeneity of both chromosomes. PAX5 has been proposed to be the target gene on 9p, while for 20q, FISH analysis implicated the involvement of the ASXL1 gene, either by a breakpoint within (n=4) or centromeric (deletion, n=12) of the gene. Molecular copy-number counting, long-distance inverse PCR and direct sequence analysis identified six dic(9;20) breakpoint sequences. In addition to the three previously reported: PAX5-ASXL1, PAX5-C20ORF112 and PAX5-KIF3B; we identified three new ones in this study: sequences 3' of PAX5 disrupting ASXL1, and ZCCHC7 disrupted by sequences 3' of FRG1B and LOC1499503. This study provides insight into the breakpoint complexity underlying dicentric chromosomal formation in acute lymphoblastic leukemia and highlights putative target gene loci.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586940      PMCID: PMC2719040          DOI: 10.3324/haematol.2008.002808

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  18 in total

1.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia.

Authors:  F Mitelman; F Mertens; B Johansson
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

2.  Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia.

Authors:  R Clark; S A Byatt; C F Bennett; M Brama; M Martineau; A V Moorman; K Roberts; L M Secker-Walker; S Richards; O B Eden; A H Goldstone; C J Harrison
Journal:  Leukemia       Date:  2000-02       Impact factor: 11.528

3.  Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.

Authors:  Anthony J Bench; Juan Li; Brian J P Huntly; Eric Delabesse; Nasios Fourouclas; Adrienne R Hunt; Panos Deloukas; Anthony R Green
Journal:  Br J Haematol       Date:  2004-12       Impact factor: 6.998

4.  Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients.

Authors:  N A Heerema; K D Maben; J Bernstein; P P Breitfeld; R S Neiman; G H Vance
Journal:  Cancer Genet Cytogenet       Date:  1996-12

Review 5.  Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature.

Authors:  Erik Forestier; Fredrika Gauffin; Mette K Andersen; Kirsi Autio; Georg Borgström; Irina Golovleva; Britt Gustafsson; Sverre Heim; Kristina Heinonen; Mats Heyman; Randi Hovland; Johann H Johannsson; Gitte Kerndrup; Richard Rosenquist; Jacqueline Schoumans; Birgitta Swolin; Bertil Johansson; Ann Nordgren
Journal:  Genes Chromosomes Cancer       Date:  2008-02       Impact factor: 5.006

6.  dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia.

Authors:  H Rieder; S Schnittger; H Bodenstein; M Schwonzen; B Wörmann; D Berkovic; W D Ludwig; D Hoelzer; C Fonatsch
Journal:  Genes Chromosomes Cancer       Date:  1995-05       Impact factor: 5.006

7.  Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.

Authors:  Qian An; Sarah L Wright; Zoë J Konn; Elizabeth Matheson; Lynne Minto; Anthony V Moorman; Helen Parker; Mike Griffiths; Fiona M Ross; Teresa Davies; Andy G Hall; Christine J Harrison; Julie A Irving; Jon C Strefford
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

8.  Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study group.

Authors:  H Behrendt; C Charrin; B Gibbons; C J Harrison; J M Hawkins; N A Heerema; B Horschler-Bötel; J L Huret; J L Laï; F Lampert
Journal:  Leukemia       Date:  1995-01       Impact factor: 11.528

9.  Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia.

Authors:  G R Jalali; Q An; Z J Konn; H Worley; S L Wright; C J Harrison; J C Strefford; M Martineau
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

10.  A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11).

Authors:  R Slater; E Smit; W Kroes; M J Bellomo; D Mühlematter; J Harbott; H Behrendt; K Hählen; A J Veerman; A Hagemeijer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

View more
  16 in total

1.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

2.  Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.

Authors:  Jiapeng Wang; Zhaomin Li; Yongzheng He; Feng Pan; Shi Chen; Steven Rhodes; Lihn Nguyen; Jin Yuan; Li Jiang; Xianlin Yang; Ophelia Weeks; Ziyue Liu; Jiehao Zhou; Hongyu Ni; Chen-Leng Cai; Mingjiang Xu; Feng-Chun Yang
Journal:  Blood       Date:  2013-11-19       Impact factor: 22.113

3.  Air1 zinc knuckles 4 and 5 and a conserved IWRXY motif are critical for the function and integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA quality control complex.

Authors:  Milo B Fasken; Sara W Leung; Ayan Banerjee; Maja O Kodani; Ramiro Chavez; Elizabeth A Bowman; Meghan K Purohit; Max E Rubinson; Emily H Rubinson; Anita H Corbett
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

4.  Familial hematological malignancies: ASXL1 gene investigation.

Authors:  W S Hamadou; R E Abed; S Besbes; V Bourdon; A Fabre; Y B Youssef; M A Laatiri; F Eisinger; V Mari; P Gesta; H Dreyfus; V Bonadona; C Dugast; H Zattara; L Faivre; S Y Jemni; T Noguchi; A Khélif; H Sobol; Z Soua
Journal:  Clin Transl Oncol       Date:  2015-08-19       Impact factor: 3.405

Review 5.  The distinct roles of zinc finger CCHC-type (ZCCHC) superfamily proteins in the regulation of RNA metabolism.

Authors:  Yishu Wang; Yu Yu; Yidan Pang; Haojun Yu; Wenqi Zhang; Xian Zhao; Jianxiu Yu
Journal:  RNA Biol       Date:  2021-05-04       Impact factor: 4.652

Review 6.  Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.

Authors:  Véronique Gelsi-Boyer; Mandy Brecqueville; Raynier Devillier; Anne Murati; Marie-Joelle Mozziconacci; Daniel Birnbaum
Journal:  J Hematol Oncol       Date:  2012-03-21       Impact factor: 17.388

7.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med High Impact Case Rep       Date:  2013-10-18

8.  Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.

Authors:  Lilach Soreq; Alessandro Guffanti; Nathan Salomonis; Alon Simchovitz; Zvi Israel; Hagai Bergman; Hermona Soreq
Journal:  PLoS Comput Biol       Date:  2014-03-20       Impact factor: 4.475

9.  A new t(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-positive chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Thomas Liehr
Journal:  Oncol Lett       Date:  2012-11-21       Impact factor: 2.967

10.  The role of dicentric chromosome formation and secondary centromere deletion in the evolution of myeloid malignancy.

Authors:  Ruth N Mackinnon; Lynda J Campbell
Journal:  Genet Res Int       Date:  2011-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.